Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-004946-41Phase 4Completed
Phase 4, single-arm trial of liraglutide, sponsored by KU Leuven. Primary endpoint: liquid nutrient tolerance to reach maximum satiation. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-004946-41.